Stocktoria

HeartBeam, Inc. BEAT

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-10-14

HeartBeam, Inc. (BEAT) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend.

2/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
$0.75 as of 2026-06-01 · -40% 1y
$0.75$2.4052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

How it ranks in Manufacturing · percentile among 1906 companies

Piotroski Fstronger than 12%
Return on equitystronger than 2%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 2/9 tests passed

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
BEATHeartBeam, Inc.2/9
MDLNMedline Inc.6/92.8444.1+11.5%
SYKSTRYKER CORP4/93.9639.3+11.2%
MMM3M CO5/95.4626.3+1.5%
BDXBECTON DICKINSON & CO6/92.2925.6+8.2%
BSXBOSTON SCIENTIFIC CORP4/92.81+19.9%
BAXBAXTER INTERNATIONAL INC5/93.86+5.7%

All Manufacturing companies →

FAQ

Is BEAT financially healthy?

HeartBeam, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).

Does BEAT pay a dividend?

No, HeartBeam, Inc. does not currently pay a dividend.

How profitable is BEAT?

In FY2025, HeartBeam, Inc. had a return on equity of -807.3%.

Source: SEC EDGAR filings · CIK 0001779372 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.